Medical and Pharmaceutical University of Oxford researchers explore AI breath analysis to transform COPD care COPD affects about three million people in the UK and is the country’s third biggest killer Joseph MortonSeptember 23, 2025
Medical and Pharmaceutical Pulmonx Corporation shares spike on record-breaking Q4 revenue Pulmonx achieved USD$83.8 million in worldwide revenue, reflecting a robust 22 per cent growth over 2023 Joseph MortonFebruary 21, 2025